Skip to content
Biodatica
Start free

Investigator

Sergey Ryzhov

MAINEHEALTH · funded by NHLBI

Companies
3

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.8M

Summed across those awards.

First award
Jul 15, 2017

Latest Apr 2, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

  • MAINEHEALTH

    ImmunologyGrant-only

    Momentum in another area
  • MAINEHEALTH

    ImmunologyGrant-only

    Momentum in another area
  • MAINEHEALTH

    ImmunologyGrant-only

    Momentum in another area

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Protective adaptive immune mechanisms after cardiac arrest

    $638k

    Apr 2, 2024NHLBIMAINEHEALTHNIH RePORTER · 11251567 (opens the source filing in a new tab)

  2. R01

    Neuregulin signaling in myeloid cells

    $582k

    Jul 15, 2017NHLBIMAINEHEALTHNIH RePORTER · 11134718 (opens the source filing in a new tab)

  3. R01

    Neuregulin signaling in myeloid cells

    $574k

    Jul 15, 2017NHLBIMAINEHEALTHNIH RePORTER · 11324237 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources